share_log

HC Wainwright & Co. Reiterates Buy on Werewolf Therapeutics, Maintains $15 Price Target

HC Wainwright & Co. Reiterates Buy on Werewolf Therapeutics, Maintains $15 Price Target

HC Wainwright & Co.重申買入 Wereolf Therapeutics,維持15美元的目標股價
Benzinga ·  2023/11/15 07:02

HC Wainwright & Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15 price target.

HC Wainwright & Co. 分析師安德烈斯·馬爾多納多重申了Werewolf Therapeutics(納斯達克股票代碼:HOWL)的買入並維持了15美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論